The Wnt genes, encoding a large family of secreted, cysteine-rich glycosylated proteins, are evolutionarily conserved among diverse organisms such as Homo sapiens, Mus musculus, Xenopus laevis, Drosophila melanogaster, and Caenorhabditis elegans (Brown and Moon, 1998; Nusse and Varmus, 1992; Wodarz and Nusse, 1998) . Genetic studies have demonstrated that the Wnt proteins serve as intercellular signaling molecules and play key roles in embryogenesis, segment polarity, central nervous system (CNS) patterning, and the control of asymmetric cell divisions (Wodarz and Nusse, 1998) . Wnt signaling events are initiated by the binding of Wnt to its receptor, Frizzled (Krasnow et al., 1995; Wong and Adler, 1993) , which leads to activation of the Dishevelled protein (Klingensmith et al., 1994; Krasnow et al., 1995; Theisen et al., 1994) . The activated Dishevelled protein enhances the phosphorylation of glycogen synthase kinase (GSK) (Cook et al., 1996) , which inhibits the ability of GSK to phosphorylate b-catenin, leading to increased stability and accumulation of b-catenin (Munemitsu et al., 1996; Pai et al., 1997; Yost et al., 1996) . bcatenin can interact with members of T cell factor (TCF)/lymphoid enhancer factor (LCF) family in the nucleus, which regulates Wnt target genes necessary for development (Wodarz and Nusse, 1998) .
Abnormal activation of the Wnt signaling pathway can lead to developmental catastrophe, such as duplication of the embryonic axis and subsequent induction of two-headed embryos in Xenopus laevis, and tumor formation in the mouse and human (Brown and Moon, 1998; Nusse and Varmus, 1992; Wodarz and Nusse, 1998) . Recent studies in Xenopus embryos have identi®ed at least four families of inhibitors of the Wnt signaling pathway, that is, Frizzled-related protein (FRP), Cerberus, Wnt-inhibitory factor-1 (WIF-1), and Dickkopf-1 (Dkk-1). Cerberus and WIF-1 physically interact with and inhibit Wnt (Glinka et al., 1997; Hsieh et al., 1999; Piccolo et al., 1999) . FRP inhibits the Wnt signaling pathway by physically associating with both Wnt and its receptor, Frizzled Finch et al., 1997; Leyns et al., 1997; Wang et al., 1997) . Dkk-1 inhibits Wnt-mediated axis duplication in Xenopus (Glinka et al., 1998) . In addition, by inhibiting the Wnt signaling pathway, Dkk-1 is sucient and necessary for head induction (Glinka et al., 1998) . Furthermore, Dkk-1 suppresses the ability of Wnt to promote cell proliferation (Fedi et al., 1999) . However, the mechanism by which Dkk-1 inhibits the Wnt signaling pathway and how Dkk-1 is regulated are still not clear.
p53 is a checkpoint protein. A large body of evidence suggests that p53 plays an important role in the regulation of numerous processes including cell cycle progression, dierentiation, and apoptosis (Argarwal et al., 1998; Almog and Rotter, 1997; Ko and Prives, 1996; Levine, 1997) . Loss or mutation of p53 in some tumors has been correlated with a marked decrease of apoptosis and/or with a marked increase of cell proliferation. As a result, p53 de®ciency can convert a slow growing tumor to a rapidly growing one (Howes et al., 1994; Pan and Griep, 1995; Symonds et al., 1994) . Indeed, tumors appear at an earlier age in Wnt-1 and ras transgenic mice lacking p53 than in animals carrying one or both alleles of the p53 gene (Donehower et al., 1995; Hundley et al., 1997) . Interestingly, the early onset of tumors in the Wnt-1 and ras transgenic mice is due to enhanced tumor cell proliferation but not decreased apoptosis in the absence of p53. Thus, p53 activities are necessary for inhibiting the acquired growth potential of tumor cells conferred by Wnt and ras (Hundley et al., 1997; Jones et al., 1997) . p53 transcriptional activity is necessary for tumor suppression (Chen, 1999; el-Deiry, 1998; Ko and Prives, 1996; Levine, 1997) . p53 directly binds to DNA in a sequence speci®c manner and transactivates cellular target genes. A number of cellular genes has been found to be induced by p53. Among these are p21 (el-Deiry et al., 1993) , GADD45 (Kastan et al., 1992) , BAX (Miyashita et al., 1994) , MDM2 (Wu et al., 1993) , BTG2 (Rouault et al., 1996) , PIGs ), 14-3-3s (Hermeking et al., 1997 , IGFBP3 (Buckbinder et al., 1995) , PI(3)K regulatory subunit p85 (Yin et al., 1998) , KILLER/DR5 , and TAP I (Zhu et al., 1999) . p21, 14-3-3s, GADD45, and BTG2 have been shown to be capable of mediating p53-dependent cell cycle arrest (Chen et al., 1996; elDeiry et al., 1993; Hermeking et al., 1997; Rouault et al., 1996; Wang et al., 1999) while BAX, p85, IGFBP3, KILLER/DR5 and PIGs may mediate apoptosis (Buckbinder et al., 1995; Miyashita et al., 1994; Polyak et al., 1997; Wu et al., 1997; Yin et al., 1998) . Recently, we found that TAP1 is speci®cally induced by both p53 and p73, which leads to enhanced transport of MHC class I peptides, suggesting that tumor surveillance can be mediated by the p53 family tumor suppressor proteins (Zhu et al., 1999) .
In our ongoing eort to identify novel p53 target genes, the ClonTech PCR-Select cDNA Subtraction Assay was performed using mRNA isolated from p53-3, a derivative of the H1299 cell line that inducibly expresses p53 under a Tet-O tetracycline-regulated promoter (Chen et al., 1996) . Several cDNA fragments that may represent gene activated by p53 were isolated. After DNA sequencing and comparison with known sequences in GenBank, one subtracted cDNA fragment was found to be derived from the Dkk-1 gene. To con®rm that Dkk-1 is speci®cally induced by wild-type but not mutant p53, Northern blot analysis was performed using Dkk-1 cDNA as probe. We found that Dkk-1 was induced by p53 in p53-3 cells ( Figure  1a , compare lanes 1 and 2). As a control, we tested expression of p21, a well-de®ned cellular p53 target gene (el-Deiry et al., 1993) . We found that p21 was also induced by p53 ( Figure 1a , compare lanes 1 and 2). Furthermore, we found that mutant p53(R249S) was incapable of inducing either Dkk-1 or p21 ( Figure 1a , compare lanes 3 and 4), consistent with the fact that Figure 1 Upregulation of Dkk-1 by p53. (a) Wild-type p53, but not p53 mutant, induces Dkk-1. A Northern blot was prepared using 10 mg of total RNA isolated from p53-3 or p53(R249S)-4 cells that were uninduced (7) or induced (+) to express wild-type p53 and mutant p53(R249S), respectively. The blot was probed with Dkk-1 cDNA, and then reprobed with both p21 and GAPDH cDNAs. (b) Dkk-1 is induced by DNA damage in cell lines that carry an endogenous wild-type p53 gene but not in cells that are p53-null-like or contain an endogenous mutant p53 gene. Northern blots were prepared using 10 mg of total RNA isolated from HCT116, U87, LS174T, HCT116E6 or MDA-MB-435 cells that were untreated (7) or treated (+) with 300 nM camptothecin for 24 h. The blots were probed with Dkk-1 cDNA, and then reprobed with p21 and GAPDH cDNAs. Northern blot analysis was performed as described previously (Zhu et al., 1998) . p21 and GAPDH probes were prepared as described previously (Zhu et al., 1998) . Dkk-1 probe, a 600 bp HindIII fragment, was prepared from human Dkk-1 cDNA Dickkopf-1, a potential mediator of p53 tumor suppression J Wang et al this tumor-derived p53 mutant is defective in transactivation (Friedlander et al., 1996) . After normalization to the level of GAPDH mRNA, we estimated that the amount of Dkk-1 in cells expressing p53 was up to 6 ± 8 times higher than in cells not expressing p53. DNA damage stabilizes and activates p53, leading to induction of p53 target genes (Giaccia and Kastan, 1998; Ko and Prives, 1996; Levine, 1997) . If Dkk-1 is a true p53 target, it would be induced by DNA damage in cells that contain an endogenous wild-type p53 gene but not in cell lines that are p53-null or contain an endogenous mutant p53 gene. To this end, we tested ®ve cell lines using the DNA damaging agent camptothecin, which is an inhibitor of topoisomerase I and can induce double strand DNA breaks (Nelson and Kastan, 1994) . These cells were treated with camptothecin and the levels of Dkk-1 and p21 determined by Northern blot analysis (Figure 1b) . We found that both Dkk-1 and p21 were induced in camptothecin-treated HCT116, LS174T, and U87 cells, Figure 2 Identi®cation of a p53-responsive element in the Dkk-1 gene. (a) Schematic representation of the Dkk-1 genomic DNA structure. The position of the potential Dkk-1 transcription start site and a potential p53 responsive element are indicated. Shown below the genomic structure are the sequence of the potential p53 responsive element and the previously characterized p53 consensus responsive element Funk et al., 1992) . R represents purine, Y pyrimidine, and W adenine or thymidine. (b) p53 binds speci®cally to the potential p53 responsive element in vitro. A 32-bp oligonucleotide fragment containing the potential p53 responsive element in the Dkk-1 gene with the following sequence; 5'-AGCTTAGCCAAGCTTTTAATGAAC-CAAGTTCA-3' (top strand) and 5'-GATCTGAACTTGGTTCATTAAAAGCTTGGCTA-3' (bottom strand), was labeled with a-32 P-dCTP. 5 ng of the labeled probe DNA was added to a mixture [20 mM HEPES (pH 7.9), 25 mM KCl, 0.1 mM EDTA, 10% glycerol, 2 mM MgCl 2 , 2 mM spermidine, 0.5 mM DTT, 0.025% NP-40, 100 ng double-stranded poly(dI:dC), and 2 mg BSA] containing 20 ng of p53 protein. The p53 protein was expressed in a baculovirus expression system and anity-puri®ed using antip53 monoclonal antibody Pab421. The p53-DNA complex was resolved in a 4% polyacrylamide gel. For`supershifting' the p53-DNA complex, 1 mg of anti-p53 monoclonal antibody Pab1801 was added in the reaction in lane 2. For competition assays, unlabeled wild-type RGC (20 and 100 ng) or mutant RGC (20 and 100 ng) were added to the reaction run in lanes 3 ± 4 and 5 ± 6, respectively Oncogene Dickkopf-1, a potential mediator of p53 tumor suppression J Wang et al which all contain wild-type p53 (Figure 1b, lanes 1 ± 6) . In contrast, Dkk-1 was not induced in p53-null-like HCT116E6 cells and MDA-MB-435 cells that carry an endogenous mutant p53 gene (Figure 1b , lanes 7 ± 10). It should be noted that in HCT116 cells, the basal level of Dkk-1 expression is much higher than that in U87 and LS174T cells. Since several potential binding sites for other transcription factors in addition to p53 are present in the promoter region of the Dkk-1 gene (more discussion below), it is possible that one or more transcription factors may be responsible for the high basal level of Dkk-1 expression in HCT116 cells.
To determine whether Dkk-1 is regulated transcriptionally by p53, we searched for a p53-responsive element in the Dkk-1 genomic DNA sequence. Using Dkk-1 cDNA as probe, we screened a human bacterial arti®cial chromosome (BAC) library and obtained a genomic DNA clone that contains the human Dkk-1 gene. An approximately 3.4-kb DNA in the promoter region of the Dkk-1 gene was sequenced. We found a potential p53-binding site located approximately 2.1-kb upstream of the Dkk-1 transcription start site ( Figure  2a ). This sequence (AGc CAAG CTT TTAATG AAc CAAG TTC) has two mismatches (cytosine in lower case instead of guanine or adenine) in the noncritical positions within the consensus p53-binding site Funk et al., 1992) .
To analyse whether p53 binds to the potential p53 responsive element, a 32-bp DNA fragment containing this element was synthesized, 32 P-labeled, and used in an electrophoretic mobility shift assay (EMSA). We found that when the puri®ed p53 protein was mixed with the DNA fragment, a complex that presumably contained both p53 and DNA was detected (Figure 2b , lane 1). The complex was`supershifted' with the antip53 monoclonal antibody Pab1801 (lane 2). We also used two other DNA fragments that contain either a wild-type or mutant p53-binding site from the ribosomal gene cluster (RGC) (Kern et al., 1991) as competitors. The unlabeled wild-type RGC competed with the 32 P-labelled 32-bp DNA fragment from the Dkk-1 gene and inhibited the formation of the p53-DNA complex in a dose-dependent manner (lanes 3 and 4). In contrast, mutant RGC was unable to compete (lanes 5 and 6). These results indicate that p53 interacts speci®cally with the potential p53 responsive element in the Dkk-1 gene.
We further examined whether the potential p53-binding site is responsive to p53 in vivo. To do this, the potential p53 responsive element was cloned upstream of a minimal c-fos promoter (Johansen and Prywes, 1994 ) and a luciferase reporter gene to generate a reporter vector, designated Dkk-1-Fluc. We also substituted four nucleotides in the potential p53 responsive element predicted to be critical for p53-binding (shown in lower case) (AGC aAAt CTT T-TAATG AAC aAAt TTC). We then generated a reporter vector designated mut-Dkk-1-Fluc. Dkk-1-Fluc or mut-Dkk-1-Fluc was cotransfected into H1299 cells with either pcDNA3 control vector or a vector that expresses one of the following: wild-type p53, p53(V143A), p53(R175H), p53(R249S), and p53 (R273H). We found that the luciferase activity for Dkk-1-Fluc was markedly increased by wild-type p53 but not by any of the p53 mutants (Figure 3a) . These results are consistent with the observation that wildtype p53, but not mutant p53(R249S), induces Dkk-1 (Figure 1a) . In contrast, the luciferase activity for mutDkk-1-Fluc was not increased by either wild-type p53 or p53 mutants (Figure 3b) . Figure 3 (a) The potential p53-binding site in the Dkk-1 gene is responsible to wild-type p53, but not p53 mutants in vivo. The 32-bp DNA fragment described in Figure 2 was cloned upstream of a minimal c-fos promoter and a ®re¯y luciferase reporter gene (Johansen and Prywes, 1994) , and the resulting construct designated Dkk-1-Fluc. Two mg of Dkk-1-Fluc was co-transfected into H1299 cells with 5 mg of pcDNA3 control vector or a vector that expresses wild-type p53, p53(V143A), p53(R175H), p53(R249S), or p53(R273H). Renilla luciferase assay vector pRL-CMV was also co-transfected as an internal control. Dual luciferase assay was performed according to the manufacturer's instruction (Promega, Madison, WI, USA). The fold increase in relative luciferase activity is a product of the luciferase activity induced by p53 divided by that induced by pcDNA3. (b) The mutated potential p53-binding site in the Dkk-1 gene is not responsive to either wild-type p53 or p53 mutants. A mutant version of the above 32-bp DNA fragment was made with the following sequence: 5'-AGCTTAGCaAAtCTTTTAATGAACaAAtTTCA-3' (top strand) and 5'-GATCTGAAaTTtGTTCATTAAAAGaTTtGCTA-3' (bottom strand). The substituted nucleotides are shown in lower case. The mutant fragment was then cloned upstream of a minimal c-fos promoter and a ®re¯y luciferase reporter gene, and the resulting construct designated mut-Dkk-1-Fluc. Luciferase assays with mut-Dkk-1-Fluc were performed as in (a)
Dickkopf-1, a potential mediator of p53 tumor suppression J Wang et al Activation of p53 leads to at least two wellcharacterized cellular responses: cell cycle arrest and apoptosis (Chen, 1999; Ko and Prives, 1996; Levine, 1997) . We wanted to determine whether Dkk-1, as a cellular target of p53, mediates p53 tumor suppression. To test this possibility, Dkk-1 was inducibly expressed in H1299 lung carcinoma and U118 glioma cells under a Tet-O-tetracycline-regulated promoter. H1299 is p53-null but U118 harbors a p53 gene that can be activated by DNA damage (data not shown). Western blots from representative H1299 cell lines and U118 cell lines showed that, when induced, Dkk-1 was expressed with an apparent molecular mass of 29 ± 35 kDa (data not shown). This range is consistent with previous reports of a slower migrating form of Dkk-1 that is N-linked glycosylated (Fedi et al., 1999; Glinka et al., 1998) . We then measured the growth rates of these cells in the absence or presence of Dkk-1. We found that Dkk-1 has little, if any, eect on the growth rates of either H1299 or U118 cells (data not shown). In addition, no cell cycle arrest and apoptosis were detected using DNA histogram analysis and annexin V staining assay (data not shown). Thus, while Dkk-1 can suppress Wnt-induced transformation (Fedi et al., 1999) , it has no eect on the proliferation of cells that are not transformed by Wnt.
In this report we have demonstrated that Dkk-1 can be induced by p53 and DNA damage. We found a p53 responsive element located approximately 2100 nucleotides upstream of the Dkk-1 transcription start site, which may mediate DNA damage induction of Dkk-1. We also found that Dkk-1 has no eect on proliferation of cells that are not transformed by Wnt. Nevertheless, previous studies have shown that Dkk-1 is a potent antagonist of Wnt signaling necessary and sucient for head induction in Xenopus (Glinka et al., 1998) and that human Dkk-1 strongly suppresses Wntinduced morphological transformation (Fedi et al., 1999) . Biochemical and genetic studies have shown that Dkk-1 antagonizes the Wnt signaling pathway, upstream of b-catenin and Dishevelled (Fedi et al., 1999; Glinka et al., 1998) . Taken together, we propose that, by inducing Dkk-1, p53 plays an important role in suppressing Wnt-mediated tumor formation. Therefore, p53 dysfunction would alleviate the negative control of Wnt signaling by Dkk-1. As a result, uncontrolled Wnt signaling may be responsible for the early onset of mammary tumors in p53-null Wnt transgenic mice (Donehower et al., 1995; Jones et al., 1997) .
Although the Wnt genes were initially identi®ed as candidate proto-oncogenes, ectopic expression of Wnt induces axis duplication in Xenopus and Wnt gene de®ciency prevents normal development of CNS, placenta, limbs, kidney, caudal somites and tailbud (Brown and Moon, 1998; Nusse and Varmus, 1992; Wodarz and Nusse, 1998) . The negative control of Wnt signaling by Dkk-1 is also necessary for normal development (Glinka et al., 1998) . Interestingly, p53 induces Dkk-1 but p53 activity is not necessary for normal development in mice (Donehower et al., 1992) . This suggests that other factor(s) must be responsible for proper expression of Dkk-1 during development. In addition to the p53 responsive element, several potential regulatory elements, such as Sp1, MyoD, STAT, Oct-1/2, C/EBP-a/b, and GATA-1, -2 and -3, are found in the promoter region of the Dkk-1 gene (data not shown). Determining whether these transcription factors regulate Dkk-1 would lead to further our understanding of the role of Dkk-1 in development.
